Silibinin attenuates Streptococcus suis serotype 2 virulence by targeting suilysin

ConclusionsOur results demonstrated that silibinin is a promising candidate for the development of anti ‐virulence therapeutic agents to treatS. suis infections.Significance and Impact of the StudyThe anti ‐virulent property of silibinin against SS2 by targeting SLY provides the possibility for the future pharmaceutical application of silibinin to prevent and treatS. suis infection.This article is protected by copyright. All rights reserved.

Source: Journal of Applied Microbiology - November 8, 2018 Category: Microbiology Authors: Xue Shen, Houru Liu, Gen Li, Xuming Deng, Jianfeng Wang Tags: Original Article Source Type: research